Personalis Inc

PSNL remains in a Stage 2 advance with sequential Higher Highs & Higher Lows and rising EMAs. Price is consolidating near its 52-week high, holding just above the rising 9- and 20-day EMAs with RSI in the mid-range and no evident exhaustion despite extreme overbought readings. The Momentum + EPS strategy favors continuation participation on absorption and shallow pullbacks, making a Buy Now on this consolidation structurally appropriate.

• ↑Tempus AI deal enhances tumor-informed MRD diagnostics and creates revenue synergies.
• ↑Secured $18.3 M Million Veteran Program contract provides stable revenue growth.
• ↓Continues unprofitable; weak profitability factors question long-term viability.